It’s been just over a year since Oregon’s first regulated service centers began providing therapeutic psilocybin trips to clients. There are now 29 licensed service centers across the state, as well ...

LONDON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, ...

COMPASS Pathways plc CMPS shared the results from research on the potential of its novel AI technologies to support its proprietary COMP360 psilocybin treatment for Treatment-Resistant Depression (TRD ...

Cybin (NYSE:CYBN), a biotech company focused on progressing psychedelic therapeutics, has announced that the FDA has given them authorization for Phase 2 clinical trials evaluating ...

Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing ...

PORTLAND, Ore. — For the first time, a scientific study has examined Oregon's pioneering model for psilocybin therapy, reflecting on a program now two years underway. Psilocybin is the psychedelic ...

This year, Oregon became the first state to introduce psilocybin therapy, and industry leaders say they’ve been learning as they go. Psilocybin is the psychedelic compound found in magic mushrooms.

MADISON, Wis.--(BUSINESS WIRE)--Usona Institute has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for psilocybin in the treatment of major depressive ...

Before Oregon even launched its legal psilocybin program last year, one of the main questions inside the industry was: How will people who might benefit from but can’t afford the experience access ...

Psyence Biomedical (PBM) announced the launch of a new psilocybin longevity research initiative in collaboration with leading researchers in South ...